Global Markets

Novo Catalent deal clears regulatory hurdles Novo Catalent deal clears regulatory hurdles

The US Federal Trade Commission (FTC) has approved the acquisition of Catalent by Novo Holdings.

byShreeyashi Ojha, Reporter

Dec 16, 2024

|

1 Min Read

Facilities & Capacity

Diabetes drug firms Sanofi, Novo expand global footprint Diabetes drug firms Sanofi, Novo expand global footprint

byShreeyashi Ojha

Dec 12, 2024

1 Min Read

Facilities & Capacity

BioMarin bolsters Ireland footprint with $63m expansion BioMarin bolsters Ireland footprint with $63m expansion

byShreeyashi Ojha

Dec 12, 2024

1 Min Read

Indonesia pledges $30m to Gavi to support global vaccinations Indonesia pledges $30m to Gavi to support global vaccinations

Dec 11, 2024

1 Min Read

WuXi Apptec and WuXi Biologics shares surge as BIOSECURE stumbles WuXi Apptec and WuXi Biologics shares surge as BIOSECURE stumbles

Dec 9, 2024

1 Min Read

Therapeutic Class

India’s pharma future relies on regulatory strength India’s pharma future relies on regulatory strength

byShreeyashi Ojha

Dec 5, 2024

1 Min Read

Facilities & Capacity

Sanofi opens AI-powered $595m facility in Singapore

Sanofi opens AI-powered $595m facility in Singapore

byShreeyashi Ojha, Reporter

Social media murmurs: Industry contemplates supply chain post-BIOSECURE

Industry contemplates supply chain post-BIOSECURE

byDan Stanton, Editorial director

Facilities & Capacity

Cytiva strengthens APAC presence with Korea plant

Cytiva strengthens APAC presence with Korea plant

byShreeyashi Ojha, Reporter

Talent dearth continues to puzzle life sciences industry, says recruitment expert

Talent dearth continues to puzzle life sciences, says recruitment expert

byDan Stanton, Editorial director

Therapeutic Class

Post-pandemic dip: Panelists discuss CGT challenges

Post-pandemic dip: Panelists discuss CGT challenges

byShreeyashi Ojha, Reporter

Facilities & Capacity

Thermo Fisher expands India footprint with bioprocess design center

Thermo Fisher expands India footprint with bioprocess design center

byShreeyashi Ojha, Reporter

Facilities & Capacity

BIOSECURE: China’s loss could be India’s gain

BIOSECURE: China’s loss could be India’s gain

byDan Stanton, Editorial director

Facilities & Capacity

Celltechna opens $54m gene therapy center in Lithuania

Celltechna opens $54m gene therapy center in Lithuania

byShreeyashi Ojha, Reporter

Upstream & Downstream Processing

Bioprocessing Q3: After 18 challenging months, is the worst behind?

Bioprocessing Q3: After 18 challenging months, is the worst behind?

byDan Stanton, Editorial director

Therapeutic Class

Investors prioritize efficacy in the CGT biz, experts say

Investors prioritize efficacy in the CGT biz, experts say

byShreeyashi Ojha, Reporter

ReiThera partners with Sabin to send Marburg vaccine to Rwanda

ReiThera partners with Sabin to send Marburg vaccine to Rwanda

byJosh Abbott, Editor, BioProcess Insider

Size matters when navigating BIOSECURE, says consultant

Size matters when navigating BIOSECURE, says consultant

byDan Stanton, Editorial director

Recipharm and Exela collaborate to boost US sterile injectable production

Recipharm and Exela collaborate to boost US sterile injectable production

byShreeyashi Ojha, Reporter

Facilities & Capacity

Ferring bolsters Adstiladrin production with Finland expansion

Ferring bolsters Adstiladrin production with Finland expansion

byShreeyashi Ojha, Reporter

Facilities & Capacity

Expansion Special: J&J, Ascend, and Aspen ramp up global biomanufacturing capacity

Expansion Special: J&J, Ascend, and Aspen ramp up global biomanufacturing capacity

byShreeyashi Ojha, Reporter

White House OSTP: ‘Whether Harris or Trump, biomanufacturing is bipartisan’

‘Whether Harris or Trump, biomanufacturing is bipartisan’

byDan Stanton, Editorial director

Mary Anne Heino wins Lifetime Achievement Award at BWB ceremony

Mary Anne Heino wins Lifetime Achievement Award at BWB ceremony

byJosh Abbott, Editor, BioProcess Insider

Facilities & Capacity

PCI forks out $365m, expands US and Ireland operations

PCI forks out $365m, expands US and Ireland operations

byShreeyashi Ojha, Reporter

Planning, patient, and payer problems hurting gene therapy rollouts

Planning, patient, and payer problems hurting gene therapies

byDan Stanton, Editorial director

Bavarian Nordic to send 500,000 doses of mpox vaccine to Africa

Bavarian Nordic to send 500,000 doses of mpox vaccine to Africa

byJosh Abbott, Editor, BioProcess Insider

KBI quietly drops mammalian manufacturing in Switzerland

KBI quietly drops mammalian manufacturing in Switzerland

byDan Stanton, Editorial director

UNICEF and partners unite to tackle mpox outbreak

UNICEF and partners unite to tackle mpox outbreak

byJosh Abbott, Editor, BioProcess Insider

Facilities & Capacity

Novartis bolsters radioligand biz with $200m expansion

Novartis bolsters radioligand biz with $200m expansion

byShreeyashi Ojha, Reporter

Roche seeking to up worldwide lab capacity in fight against mpox

Roche seeking to up worldwide lab capacity in fight against mpox

byJosh Abbott, Editor, BioProcess Insider

Facilities & Capacity

Bora completes acquisition of Emergent’s Camden plant

Bora completes acquisition of Emergent’s Camden plant

byShreeyashi Ojha, Reporter

Facilities & Capacity

From humble beginnings to global ambitions: eXmoor’s CGT journey

From humble beginnings to global ambitions: eXmoor’s CGT journey

byShreeyashi Ojha, Reporter

Germfree, Caring Cross to bring affordable CAR-Ts to Brazil

Germfree, Caring Cross to bring affordable CAR-Ts to Brazil

byShreeyashi Ojha, Reporter

Facilities & Capacity

Vaccine maker Bavarian Nordic readies production for mpox risk

Vaccine maker Bavarian Nordic readies production for mpox risk

byDan Stanton, Editorial director

Facilities & Capacity

CDMO Lonza secures £30m subsidy for UK biologics site

CDMO Lonza secures £30m subsidy for UK biologics site

byShreeyashi Ojha, Reporter